Small Cap Profiles
NV5 Holdings: A Diversified & Growing Play on Infrastructure
WHITEFISH, MT / ACCESSWIRE / December 2, 2014 / Micro-cap stocks don't always receive a lot of attention in the market, especially given the fewer analysts covering the space and institutional limitations on investments via mutual funds. However, some micro-cap stocks offer compelling growth and value opportunities that individual investors shouldn't ignore given their potential to eventually up-list and become more widely known.
NV5 Holdings Inc. (NVEE) is a micro-cap stock trading with a $75 million market capitalization that provides professional and technical engineering and consulting solutions across many different industries. While larger competitors, like Tetra Tech Inc. (NASDAQ:TTEK) and Hill International Inc. (NYSE:HIL), command higher market capitalizations, investors may want to take a closer look at the stock.
Good Times: Colorado's Next Rapidly Growing Restaurant Franchise
Most investors know Colorado's restaurant industry for Chipotle Mexican Grill Inc.'s (NYSE:CMG) meteoric rise from $40.00 per share in 2006 to nearly $650.00 per share today, yielding a $20 billion juggernaut. With the stock trading at a 50x price-earnings multiple, investors may want to take a closer look at lesser-known chains that may offer more upside in the restaurant industry.
In this article, we'll take a look at Good Times Restaurants Inc. (GTIM) and its plan to capitalize on the high-end QSR market with two innovative concepts.
JetPay: An Experienced Team Consolidating the Market
Since its humble beginnings in 1974, Automated Clearing House ("ACH") transactions have grown into one of the largest, safest, and most efficient payment systems in the world. The network now moves nearly $39 trillion each year through approximately 22 billion electronic financial transactions, including direct deposit, social security, government benefits, bill payments, and much more.
Payment processing is now a multi-billion dollar business dominated by companies like Total Systems Services Inc. (NYSE:TSS), Fiserv Inc. (NASDAQ:FISV), and Fidelity National Information Services (NYSE:FIS). Many smaller providers have been acquired over the years, including eBay Inc.'s (NASDAQ:EBAY) acquisition of Braintree Payment Solutions Inc. for $800 million in 2013.
In this article, we'll take a look at a micro-cap stock that's building its own niche within the payments industry, backed by an impressive management team.
Aeolus Pharma: Leveraging Biodefense Funding for Oncology
The Biomedical Advanced Research and Development Authority - known as BARDA - is a subsection of the U.S. Department of Health and Human Services responsible for an integrated and systematic approach to the development and purchase of necessary vaccines, drugs, therapies, and diagnostic tools for use during public health emergencies ranging from terror attacks to infectious diseases.
As a part of its efforts, BARDA's Project BioShield is tasked with stockpiling medical countermeasures for the treatment of acute radiation syndrome ("ARS") associated neutropenia, chemical threats, and radiation-induced thermal burns, in addition to its recently procured stockpiles on anthrax and smallpox vaccines. The available funding for these programs exceeds $2 billion, which creates a big opportunity.
In this article, we'll take a look at how one micro-cap company plans on leveraging the funding for biodefense to push forward potential oncology indications.
Aeolus Pharmaceuticals Inc. (AOLS) trades with a market capitalization of just $35 million, but the programs in its pipeline could mean big business. In February of 2011, the company was awarded a contract fully valued at $118 million from BARDA to develop a treatment for lung acute radiation syndrome. The funding helped set the stage for its successful AEOL 10150 program.
Legal Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
SOURCE: Emerging Growth LLC
